RANKL promotes migration and invasion of hepatocellular carcinoma cells via NF-κb-mediated epithelial-mesenchymal transition

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Song, Fang Nan ^a   Duan, Meng ^a   Liu, Long Zi ^a   Wang, Zhi Chao ^a   Shi, Jie Yi ^a   Yang, Liu Xiao ^a   Zhou, Jian ^a   Fan, Jia ^a   Gao, Qiang ^a   Wang, Xiao Ying ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NERVE CELL ADHESION MOLECULE; OSTEOCLAST DIFFERENTIATION FACTOR; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR TWIST; UVOMORULIN; ANTINEOPLASTIC AGENT; CADHERIN; CDH2 PROTEIN, HUMAN; COLLAGENASE; HELENALIN; LEUKOCYTE ANTIGEN; NUCLEAR PROTEIN; SESQUITERPENE; SNAIL FAMILY TRANSCRIPTION FACTORS; TNFRSF11A PROTEIN, HUMAN; TNFSF11 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TWIST1 PROTEIN, HUMAN; VIMENTIN;

ARTICLE; CARCINOMA CELL; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LIVER CELL CARCINOMA; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; AGONISTS; ANTAGONISTS AND INHIBITORS; CARCINOMA, HEPATOCELLULAR; CELL MOTION; DIFFUSION CHAMBER; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; LIVER NEOPLASMS; METABOLISM; PATHOLOGY; TUMOR CELL LINE; TUMOR INVASION;

ANTIGENS, CD; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CADHERINS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; COLLAGENASES; DIFFUSION CHAMBERS, CULTURE; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; NEOPLASM INVASIVENESS; NF-KAPPA B; NUCLEAR PROTEINS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; SESQUITERPENES; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TWIST TRANSCRIPTION FACTOR; VIMENTIN;

EID: 84907534806     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0108507     Document Type: Article

References (35)

1. El-Serag HB (2011) Hepatocellular carcinoma. N Engl J Med 365: 1118-1127.
2. Yang JD, Roberts LR (2010) Hepatocellular carcinoma: A global view. Nat Rev Gastroenterol Hepatol 7: 448-458.
3. Budhu A, Forgues M, Ye QH, Jia HL, He P, et al. (2006) Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. Cancer Cell 10: 99-111.
4. Gupta GP, Massague J (2006) Cancer metastasis: building a framework. Cell 127: 679-695.
5. Yang J, Weinberg RA (2008) Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 14: 818-829.
6. Thiery JP, Acloque H, Huang RY, Nieto MA (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139: 871 -890.
7. Kalluri R, Weinberg RA (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119: 1420-1428.
8. Savagner P (2001) Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition. Bioessays 23: 912-923.
9. Zeisberg M, Neilson EG (2009) Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 119: 1429-1437.
10. Sanchez-Tillo E, Liu Y, de Barrios O, Siles L, Fanlo L, et al. (2012) EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness. Cell Mol Life Sci 69: 3429-3456.
11. Min C, Eddy SF, Sherr DH, Sonenshein GE (2008) NF-kappaB and epithelial to mesenchymal transition of cancer. J Cell Biochem 104: 733-744.
12. Ghosh S, Karin M (2002) Missing pieces in the NF-kappaB puzzle. Cell 109 Suppl: S81-S96.
13. Karin M, Lin A (2002) NF-kappaB at the crossroads of life and death. Nat Immunol 3: 221-227.
14. Schmitz ML, Bacher S, Kracht M (2001) I kappa B-independent control of NF-kappa B activity by modulatory phosphorylations. Trends Biochem Sci 26: 186 -190.
15. Vermeulen L, De Wilde G, Notebaert S, Van den BW, Haegeman G (2002) Regulation of the transcriptional activity of the nuclear factor-kappaB p65 subunit. Biochem Pharmacol 64: 963-970.
16. Wong BR, Josien R, Lee SY, Sauter B, Li HL, et al. (1997) TRANCE (tumor necrosis factor [TNF] -related activation-induced cytokine), a new TNF family member predominantiy expressed in T cells, is a dendritic cell-specific survival factor. J Exp Med 186: 2075-2080.
17. Anderson DM, Maraskovsky E, Billingsley WL, Dougall WC, Tometsko ME, et al. (1997) A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390: 175-179.
18. Leibbrandt A, Penninger JM (2008) RANK/RANKL: regulators of immune responses and bone physiology. Ann N Y Acad Sci 1143: 123-150.
19. Cheng ML, Fong L (2014) Effects of RANKL-Targeted Therapy in Immunity and Cancer. Front Oncol 3: 329.
20. Beristain AG, Narala SR, Di Grappa MA, Khokha R (2012) Homotypic RANK signaling differentially regulates proliferation, motility and cell survival in osteosarcoma and mammary epithelial cells. J Cell Sci 125: 943-955.
21. Palafox M, Ferrer I, Pellegrini P, Vila S, Hernandez-Ortega S, et al. (2012) RANK induces epithelial-mesenchymal transition and sternness in human mammary epithelial cells and promotes tumorigenesis and metastasis. Cancer Res 72: 2879-2888.
22. Hsu CJ, Lin TY, Kuo CC, Tsai CH, Lin MZ, et al. (2010) Involvement of integrin up-regulation in RANKL/RANK pathway of chondrosarcomas migration. J Cell Biochem 111: 138-147.
23. Armstrong AP, Miller RE, Jones JC, Zhang J, Keller ET, et al. (2008) RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes. Prostate 68: 92-104.
24. Chen LM, Kuo CH, Lai TY, Lin YM, Su CC, et al. (2011) RANKL increases migration of human lung cancer cells through intercellular adhesion molecule-1 up-regulation. J Cell Biochem 112: 933-941.
25. Gao Q, Qiu SJ, Fan J, Zhou J, Wang XY, et al. (2007) Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol 25: 2586-2593.
26. Tsubaki M, Komai M, Fujimoto S, Itoh T, Imano M, et al. (2013) Activation of NF-kappaB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines. J Exp Clin Cancer Res 32: 62.
27. Gao Q, Zhao YJ, Wang XY, Qiu SJ, Shi YH, et al. (2012) CXCR6 upregulation contributes to a proinflammatory tumor microenvironment that drives metastasis and poor patient outcomes in hepatocellular carcinoma. Cancer Res 72: 3546-3556.
28. Santini D, Perrone G, Roato I, Godio L, Pantano F, et al. (2011) Expression pattern of receptor activator of NFkappaB (RANK) in a series of primary solid tumors and related bone metastases. J Cell Physiol 226: 780 -784.
29. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
30. Miyoshi A, Kitajima Y, Sumi K, Sato K, Hagiwara A, et al. (2004) Snail and SIP1 increase cancer invasion by upregulating MMP family in hepatocellular carcinoma cells. Br J Cancer 90: 1265-1273.
31. Hofmann UB, Houben R, Brocker EB, Becker JC (2005) Role of matrix metalloproteinases in melanoma cell invasion. Biochimie 87: 307-314.
32. Borghaei RC, Rawlings PJ, Javadi M, Woloshin J (2004) NF-kappaB binds to a polymorphic repressor element in the MMP-3 promoter. Biochem Biophys Res Commun 316: 182-188.
33. Adya R, Tan BK, Chen J, Randeva HS (2008) Nuclear factor-kappaB induction by visfatin in human vascular endothelial cells: its role in MMP-2/9 production and activation. Diabetes Care 31: 758-760.
34. Sasaki A, Ishikawa K, Haraguchi N, Inoue H, Ishio T, et al. (2007) Receptor activator of nuclear factor-kappaB ligand (RANKL) expression in hepatocellular carcinoma with bone metastasis. Ann Surg Oncol 14: 1191 -1199.
35. Yang MH, Chen CL, Chau GY, Chiou SH, Su CW, et al. (2009) Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma. Hepatology 50: 1464-1474.